Over 80% of rare diseases may be genetic in origin, and have a significant impact on our healthcare system. Children with rare disease often have a long diagnostic journey, taking over 7 years to reach a diagnosis through 8 different physicians and nearly $20,000 invested in the wrong genetic tests.

Join us and experience the value of clinical genome sequencing. You will understand what genome sequencing is and is not, how it changed the life of one family, and how clinicians use it. Learn how access and use a value assessment tool to see if genome sequencing can benefit your population.

Click here for additional information and registration details.

Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.